One third of people with HIV in US study are not virally suppressed on antiretroviral therapy
How do we treat the world? Experts discuss moving to universal HIV treatment
Sofosbuvir + daclatasvir demonstrates high cure rates for people with HIV and HCV co-infection
Retreat of international donors and neglect of national governments threatens harm reduction services
Emergency needle exchange in Indiana reduces HIV and HCV risk for people who inject drugs
US study provides 'real world' evidence about which patients with hepatitis C should be prioritised for therapy
Opioid substitution therapy, especially in combination with needle exchange, reduces transmission of hepatitis C
